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K e y  M e s s a g e s 
1. Full-length HBx and two natural C-terminal 
truncated HBx mutants (1-130 and 1-119 
amino acid residues) do not alter the mitotic 
checkpoint control in hepatocytes or deregulate 
the expression of mitotic checkpoint proteins in 
hepatocellular carcinoma (HCC) cells.
2. The inducible gene expression systems are useful 
tools to characterise the role of HBx protein in 
Role of hepatitis B virus X protein in liver cancer
Introduction
An estimated 350 million people worldwide are 
chronically infected with hepatitis B virus (HBV).1 In 
Southeast Asia and Mainland China, including Hong 
Kong, the prevalence of HBV infection is high (10% 
in Hong Kong). Hepatocellular carcinoma (HCC) is a 
dreaded complication of chronic HBV infection; 55% 
of liver cancers worldwide occur in China including 
Hong Kong. HBV is a partial double-stranded DNA 
virus that comprises four known open reading 
frames: the viral DNA polymerase (P), viral envelope 
(surface antigens) proteins (PreS1, PreS2 or S), core 
protein (PreC or C), and HBV X protein (HBx). 
Among these four genes, HBx is the most frequently 
integrated and often considered an important factor 
in HBV-related hepatocarcinogenesis.2 Integration 
of HBV DNA into the host genome is common in 
HCC and this may lead to alteration of the host 
cells by disrupting expression of cellular genes that 
are important for cell growth, survival, and cellular 
differentiation.3,4 Random HBV genome integration 
can also lead to truncation of the HBV genome, 
especially the HBx gene at the C-terminus.5-7 
The function of HBx in HBV-associated HCC 
has been characterised, but its functional role in 
hepatocarcinogenesis remains unclear. This study 
aimed to (1) investigate the alteration by HBx of cell 
targets in HCC cells, (2) delineate the role of HBx 
in deregulation of mitotic checkpoint control, and 
(3) characterise the cellular effects of natural HBx 
mutants in HCC.
Methods
This study was conducted from September 2006 to 
August 2009. 
In vitro functional characterisation of HBx in 
a HCC cell line and an immortalised normal 
liver cell line
Full-length HBx DNA (ayw subtype, GenBank No.: 
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U95551) was amplified from the HBx/pcDNA3.1+ 
plasmid8 and subcloned into Myc/pcDNA3.1+ 
and Myc/pLVX Tight Puro vectors. Two natural 
C-terminal truncation HBx mutants, HBxΔC1 (1 - 
130 amino acid [aa]) and HBxΔC2 (1 - 119 aa) were 
generated and subcloned into Myc/pcDNA3.1+, 
Myc/pLVX Tight Puro, and Myc/pIND-Hygro 
vectors. Transient doxycycline- and ecdysone-
inducible expression systems of full-length HBx, 
HBxΔC1 and HBxΔC2 were established for in vitro 
functional characterisation in the non-HBV infected 
immortalised normal liver cell line LO2 and HepG2 
hepatoma cells.
RNA extraction and semi-quantitative 
RT-PCR
Total RNA was extracted from HCC cell lines 
using TriZOL (Invitrogen, Grand Island, NY, USA), 
according to the manufacturer’s protocol. Primers 
for MAD1 (5’-CACCATGGTTTT ATCCACCC-3’ 
and 5’-GCATCCAAGTTCTGCTGACA-3’) , 
MAD2 (5’-CTTTTGTTTGTG TCCCTGGC-3’ 
and 5’-GTCATTGACAGGAATTTTGTAGG-3’), 
BUBR1 (5’- TGTAGCTCCGAGGGCAGG-3’ and 
5’-TTGAGAGCACCTCCTACACG-3’), BUB1 
(5’-GTGGAGACATCCCATGAGGATC-3’ and 
5’-GGATCTTCTGCAATGGCAGCG-3’) and 
BUB3 (5’-CGGGAAACGTTGCTTCTG-3’ and 5’- 
TCTAGTCCTCCACTCCAG-3’) were used. β-Actin 
(primer set of 5’-GTGGGGCGCCCCAGGACACA-3' 
and 5'-CTCCTTAATGTCACGCACGATTTC-3') was 
used as a reference for the amount of cDNA added in 
the PCR reactions. 
Western blot analysis 
Cells were lysed in sodium dodecyl sulphate–
containing buffer and equal amounts of protein 
were separated on SDS-PAGE gel for western blot 
analysis. Immunodetection was performed using 
anti-c-Myc (Santa Cruz, CA, USA), anti-Flag (Sigma-
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Aldrich, St Louis, MO, USA), anti-p53 (Santa Cruz), 
anti-p21 (Santa Cruz), anti-NF-κB p50 (Santa Cruz), 
anti-NF-κB p65 (Santa Cruz), anti-MAD1 (Bethyl 
Laboratories, Montgomery, TX, USA), anti-MAD2 
(BD Transduction, San Jose, CA, USA), anti-BUBR1 
(BD Transduction), and anti-α-tubulin (Sigma-
Aldrich) antibodies.
Mitotic index measurement for analysis of 
mitotic checkpoint competence 
Two ×105 cells were seeded in six-well plates 
overnight and medium containing nocodazole at 
0.2 μg/mL or colcemid at 0.1 μg/mL was applied 
to the cultures. Cells were collected at 24-
hours, fixed in 3.7% of formaldehyde, stained 
with 4’,6-diamidino-2-phenylindole (DAPI), 
and examined under an inverted fluorescence 
microscope. Cells with condensed nuclear DNA 
were considered as undergoing mitosis. To 
measure the mitotic index (percentage of viable 
cells arrested in mitosis), at least 300 cells were 
counted for each experiment using fluorescence 
microscopy. Data points represent the average 
results from two independent experiments. A cell 
line with mitotic index <50% following nocodazole 
or colcemid treatment was regarded as having 
mitotic checkpoint incompetence.9
Results
Inducible HBx-expression systems in HCC 
and immortalised normal liver cell lines
Transient overexpression of the full-length form of 
HBx (ayw subtype) caused a marked induction of 
cell death in the colony formation assay. Therefore, 
to stably express HBx for further functional studies, 
an inducible system—the doxycycline-inducible 
mammalian expression system—was used to study 
the effects of HBx. Adding doxycycline to the culture 
medium induced expression of the HBx protein in 
HepG2 and LO2 cells. The level of HBx expression 
closely correlated with withdrawal of doxycycline 
(data not shown). In addition, an ecdysone-inducible 
expression system was established in LO2 cells. 
Adding ponasterone A to the culture medium 
induced expression of HBx in LO2 cells. These 
inducible mammalian expression systems were 
useful to study the cellular effects of HBx.
Effect of full-length HBx on cellular targets, 
p53, p21 and NF-κB, in HepG2 and LO2 cells
No significant change was noted in the protein 
expression of cell cycle regulators, p53 and p21waf1/
cip1, in HepG2 or LO2 cells with induced expression 
of full-length HBx. Similarly, there was no significant 
change in the protein expression levels of NF-κB p65 
or p50.
Effect of full-length HBx, HBxΔC1 and 
HBxΔC2 on mitotic checkpoint control
To determine whether HBx impaired mitotic 
checkpoint control, the mitotic checkpoint 
competence was examined by treating cells 
with either nocodazole or colcemid, both being 
microtubule-disturbing agents. A cell line with 
mitotic index <50% after nocodazole or colcemid 
treatment was considered to have mitotic checkpoint 
incompetence.9 There was no significant difference 
in the mitotic index between the LO2 cells stably 
expressing Myc-tagged full-length HBx and myc-
tagged vector control (cell lines were treated with 
oxycycline for at least 7 days), indicating that full-
length HBx had no significant effect on the mitotic 
checkpoint competence of LO2. There was also 
no significant difference in the mitotic checkpoint 
control in the presence of nocodazole or colcemid 
in LO2 cells expressing HBxΔC1 or HBxΔC2, 
compared with those expressing full-length HBx 
or vector control. These results suggest that the 
inducible expression of both full-length and C-
terminal truncated HBx does not alter the mitotic 
checkpoint control of LO2 cells. As HepG2 cells 
were mitotic checkpoint incompetent,9 the mitotic 
checkpoint competence assay was not performed on 
HepG2 cells expressing the various forms of HBx. 
Effect of full-length HBx, HBxΔC1 and 
HBxΔC2 on expression of mitotic checkpoint 
genes
To further investigate whether full-length HBx, 
HBxΔC1, and HBxΔC2 altered the expression of 
important mitotic checkpoint gene regulators (such 
as MAD1-3, BUB1, and BUB3), semi-quantitative 
RT-PCR and western blot analysis were performed. 
There was no significant change in expression at 
both mRNA and protein levels of MAD1, MAD2, 
and MAD3/BUBR1 in LO2 cells expressing full-
length HBx, HBxΔC1, or HBxΔC2, compared with 
the vector control. There was also no significant 
difference in mRNA expression of other mitotic 
checkpoint genes, BUB1 and BUB3, LO2 cells 
expressing the various forms of HBx, compared with 
the vector control.
Discussion
HBV genomic DNA integration or mutation 
leads to COOH-truncation of the HBx protein in 
human HCC.5-7,10 COOH-truncated HBx DNA has 
been identified in 46% (23/50) of HBV-associated 
HCC tissue from HCC patients with chronic HBV 
infection.11 About 79% of human HCCs from China 
have COOH-truncated HBx transcript in tumour 
tissue,5 suggesting that COOH-truncation of HBx is 
frequent in HCC in the Hong Kong population.
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 Cell invasiveness and up-regulation of 
uroplasminogen (uPA) is enhanced via NF-kappa 
B activation in HepG2 cells expressing full-length 
HBx.8 To determine whether HBx deregulated 
cellular targets in HCC, the protein expression of 
NF-κB and some cell cycle regulators (such as p53 
and p21) were evaluated. There was no signification 
alteration in the expression of p53, p21, or NF-κB 
(p50/p65) when full-length HBx was expressed in 
HepG2 and LO2 cells with tetracycline inducible 
systems. Different subtypes or protein sequences of 
HBx can behave differently in repressing p21 protein 
expression in HCC cells12; the subtypes of HBx may 
be an influential factor. 
 DNA aneuploidy is frequent in human HCC.13 
One of the leading causes of DNA aneuploidy 
is dysfunction of mitotic checkpoint regulation 
including alteration in abundance of mitotic 
checkpoint proteins or disruption of protein-protein 
interaction by viral proteins such as Tax protein 
in human T cell leukaemia virus type 1.9,14 In this 
study using Co-IP assays, full-length HBx interacted 
with the full-length form of MAD3/BUBR1 
and p55cdc, but not with MAD1 or MAD2. As 
BUBR1 can interact with p55cdc when the mitotic 
checkpoint control is activated, we investigated 
whether the interaction between HBx and BUBR1 
involved p55cdc, and a BUBR1 mutant, in which 
the putative p55cdc binding sites at BUBR1 protein 
were mutated, was constructed. The BUBR1 mutant 
could still interact with full-length HBx in the Co-IP 
assay, suggesting that HBx-BUBR1 interaction does 
not require the presence of p55cdc protein (data not 
shown). This is in line with a finding that HBx might 
alter the interaction between BUBR1 and p55cdc 
in mitotic checkpoint activation.15 Nonetheless, 
ectopic expression of HBx did not change the 
mitotic checkpoint status of LO2 cells, and the result 
differed from that observed in the HBx-expressing 
Chang liver cell line.15 Such discrepancy may be due 
to differences in the cell lines and the subtype of HBx 
(ayw subtype) used in the experiments. 
 To investigate the effect of C-terminal 
truncated HBx on mitotic checkpoint control, two 
natural C-terminal truncated forms of HBx found in 
human HCC were used: one with a breakpoint at 130 
aa (HBxΔC1) and the other at 119 aa (HBxΔC2).5,7,16 
Similar to full-length HBx, no significant difference 
was noted in the expression of mitotic checkpoint 
genes or alteration in mitotic checkpoint control 
in HBxΔC1- or HBxΔC2-expressing LO2 cells 
after treatment with nocodazole or colcemid. To 
determine whether HBx affects HCC tumour growth 
in nude mice, previous study has established full-
length HBx stable knockdown cell in PLC/PRF/5 
HCC cells and shown that knockdown of HBx 
inhibited HCC tumour growth.17 In our study, the 
HepG2 and LO2 cells with inducible expression of 
full-length HBx and two truncated HBx forms were 
established to test the tumourigenicity in nude mice; 
neither HepG2 nor LO2 cells were tumourigenic. 
Therefore, the effect of C-terminal truncated HBx in 
tumour development requires further investigation 
using other cell line models. Our data suggested 
that neither full-length HBx (ayw subtype) nor 
natural C-terminal truncated HBx (1-130 and 1-119 
amino acid) altered mitotic checkpoint control in 
hepatocytes.
Conclusions
Random HBV integration leads to C-terminus 
truncation of HBx in HCC. Our data suggest that 
neither full-length HBx (ayw subtype) nor natural C-
terminal truncated forms of HBx (1-130 and 1-119 
amino acid) alter the mitotic checkpoint control in 
hepatocytes or deregulate the expression of mitotic 
checkpoint proteins/genes in HCC cells.
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